These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24144966)

  • 1. Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population.
    Liu BL; Yang SY; Liu W; Xue LQ; Chen X; Pan CM; Gu ZH; Zhan M; Zhang XM; Liang J; Gao GQ; Du WH; Yuan GY; Ying R; Zhao SX; Song HD
    Eur J Endocrinol; 2014 Jan; 170(1):109-19. PubMed ID: 24144966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.
    Brand OJ; Barrett JC; Simmonds MJ; Newby PR; McCabe CJ; Bruce CK; Kysela B; Carr-Smith JD; Brix T; Hunt PJ; Wiersinga WM; Hegedüs L; Connell J; Wass JA; Franklyn JA; Weetman AP; Heward JM; Gough SC
    Hum Mol Genet; 2009 May; 18(9):1704-13. PubMed ID: 19244275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts.
    Płoski R; Brand OJ; Jurecka-Lubieniecka B; Franaszczyk M; Kula D; Krajewski P; Karamat MA; Simmonds MJ; Franklyn JA; Gough SC; Jarząb B; Bednarczuk T
    PLoS One; 2010 Nov; 5(11):e15512. PubMed ID: 21124799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dense mapping study of six European AITD susceptibility regions in a large Chinese Han Cohort of Graves' disease.
    Liu W; Zhang QY; Yuan FF; Wang HN; Zhang LL; Ma YR; Ye XP; Zhang MM; Song ZY; Li SX; Du WH; Liang J; Zhang XM; Gao GQ; Zhao SX; Chen FL; Song HD;
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):840-848. PubMed ID: 30176063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity.
    Stefan M; Wei C; Lombardi A; Li CW; Concepcion ES; Inabnet WB; Owen R; Zhang W; Tomer Y
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12562-7. PubMed ID: 25122677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping of thyroglobulin gene identifies two independent risk loci for Graves' disease in Chinese Han population.
    Xuan M; Zhao SX; Yan CY; Yang J; Li Y; Song LG; Song HD; Zhang XZ
    Ann Transl Med; 2019 Sep; 7(18):434. PubMed ID: 31700870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves' disease in a Chinese Han population.
    Xue L; Pan C; Gu Z; Zhao S; Han B; Liu W; Yang S; Yu S; Sun Y; Liang J; Gao G; Zhang X; Yuan G; Li C; Du W; Chen G; Chen J; Song H
    PLoS One; 2013; 8(12):e84514. PubMed ID: 24386393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Analysis of Single Nucleotide Polymorphisms in C1QTNF6, RAC2, and an Intergenic Region at 14q32.2 with Graves' Disease in Chinese Han Population.
    Zhang XH; Shen M; Liu L; Li FM; Hu PC; Hua Q; Zhang J; Pang LN; Lu HW; Wang ZM; Chu X; Huang W
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):479-484. PubMed ID: 28665696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves' Disease and Hashimoto's Hypothyroidism.
    Zhang QY; Liu W; Li L; Du WH; Zuo CL; Ye XP; Zhou Z; Yuan FF; Ma YR; Sun F; Yu SS; Xie HJ; Zhang CR; Ying YX; Yuan GY; Gao GQ; Liang J; Zhao SX; Song HD
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32246145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the TSHR gene with Graves' disease: the first disease specific locus.
    Dechairo BM; Zabaneh D; Collins J; Brand O; Dawson GJ; Green AP; Mackay I; Franklyn JA; Connell JM; Wass JA; Wiersinga WM; Hegedus L; Brix T; Robinson BG; Hunt PJ; Weetman AP; Carey AH; Gough SC
    Eur J Hum Genet; 2005 Nov; 13(11):1223-30. PubMed ID: 16106256
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine mapping MHC associations in Graves' disease and its clinical subtypes in Han Chinese.
    Chu X; Yang M; Song ZJ; Dong Y; Li C; Shen M; Zhu YQ; Song HD; Chen SJ; Chen Z; Huang W
    J Med Genet; 2018 Oct; 55(10):685-692. PubMed ID: 29987165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease.
    Hiratani H; Bowden DW; Ikegami S; Shirasawa S; Shimizu A; Iwatani Y; Akamizu T
    J Clin Endocrinol Metab; 2005 May; 90(5):2898-903. PubMed ID: 15741259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in Taiwan.
    Liao WL; Wan L; Wang TY; Chen CC; Tse SS; Lu CH; Tsai FJ
    BMC Ophthalmol; 2014 Feb; 14():15. PubMed ID: 24517461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
    McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
    PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.